What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 6 minute read Pharma Industry News Wave Life Sciences unveils early WVE-007 obesity trial results showing fat reduction without muscle loss Discover how Wave Life Sciences’ WVE-007 delivered fat loss without muscle loss in its Phase 1 obesity trial and what it means for the obesity drug market. bySoujanya RaviDecember 8, 2025